kff employer health benefits survey 2025 glp-1 coverage Perspectives from employers on the costs and issues associated with covering agonists for weight loss Summary of the KFF 2025

Mind and body wellness support with MB System and Protandim NRF2 Synergizer Enhanced cognitive clarity, focus, and mental performance via MB Healthy Balance Supports sustainable weight management by increasing GLP-1 levels (avg

That puts it broadly in line with the upper range seen in late-stage trials of Eli Lillys oral GLP-1 candidate orforglipron, and approaching the efficacy range of established injectable therapies

When Nutrition Therapy Isnt Enough If nutritional strategies arent sufficient to manage side effects, consider recommending over-the-counter medications

Capacity continues to fluctuate, attachment points remain elevated and underwriting discipline has tightened across higher hazard general liability and excess and umbrella layers

Market Segmentation and Scope 1.2